Intersect Ent Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Intersect Ent Inc (XENT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Peer Data As of Q1 2022
Competitors
130
Peer Group Market Share
100.00 %
Revenue Growth Y/Y
-11.32 %
Net Margin
-267.01 %
Key Findings: Intersect Ent Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 104M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-17.0% annualized vs trailing 12 months).
- Peer revenue share: Intersect Ent Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
XENT Sales vs. its Competitors, Q1 2022
Intersect Ent Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/XENT/competitors
https://api.csimarket.com/api/v1/companies/XENT/relationships
https://api.csimarket.com/api/v1/companies/XENT/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Connect Your AI Assistant
For context: the Medical Equipment & Supplies industry grew revenue 14.5% year over year, combined, vs -11.3% for Intersect Ent Inc. Intersect Ent Inc's share of combined industry revenue moved from 0.02% to 0.02%, a loss of 0.01 percentage points.
Intersect Ent Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Intersect Ent Inc | No | Yes | Yes | Yes |
| High-Confidence Competitors (62) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
XENT Stock Performance relative to its Competitors
XENT
Competitors (weighted)
Percent change over the selected range
XENT Stock Performance relative to High-Confidence Competitors
XENT
High-Confidence Competitors (equal-weighted, 64)
Percent change over the selected range
Intersect Ent Inc's Competitors Named by the Company
Competitive relationships identified from Intersect Ent Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Angiodynamics Inc | Company report | 85% |
| Neuroone Medical Technologies Corp | Company report | 85% |
| Senseonics Holdings Inc | Company report | 85% |
| Edwards Lifesciences Corporation | Company report | 85% |
| Sintx Technologies Inc | Company report | 85% |
| Neuropace Inc | Company report | 85% |
| Bone Biologics Corporation | Company report | 85% |
| Orchestra Biomed Holdings Inc | Company report | 85% |
| Pulse Biosciences Inc | Company report | 85% |
| Si bone inc | Company report | 85% |
| Ss Innovations International Inc | Company report | 85% |
| Bioventus Inc | Company report | 85% |
| Penumbra Inc | Company report | 85% |
| Catheter Precision Inc | Company report | 85% |
| Atricure Inc | Company report | 85% |
| Inspiremd Inc | Company report | 85% |
| Intuitive Surgical Inc | Company report | 85% |
| Sharps Technology Inc | Company report | 85% |
| Usbc Inc | Company report | 85% |
| Streamex Corp | Company report | 85% |
| Integra Lifesciences Holdings Corp | Company report | 85% |
| Autonomix Medical Inc | Company report | 85% |
| Encision Inc | Company report | 85% |
| Insulet Corporation | Company report | 85% |
| Movano Inc | Company report | 85% |
| Avinger Inc | Company report | 85% |
| Acutus Medical Inc | Company report | 85% |
| Shockwave Medical Inc | Company report | 85% |
| Electromedical Technologies Inc | Company report | 85% |
| Motus Gi Holdings Inc | Company report | 85% |
| Modular Medical Inc | Company report | 85% |
| Abbott Laboratories | Company report | 85% |
| Glucotrack Inc | Company report | 85% |
| Blackstone Life Sciences Advisors L.L.C. | Company report | 85% |
| Avanos Medical Inc | Company report | 85% |
| Koninklijke Philips Nv | Company report | 85% |
| Nuwellis Inc | Company report | 85% |
| Globus Medical Inc | Company report | 85% |
| Capsovision Inc | Company report | 85% |
| Xtant Medical Holdings Inc | Company report | 85% |
| Artivion Inc | Company report | 85% |
| Northview Acquisition Corp | Company report | 85% |
| Stryker Corp | Company report | 85% |
| Nevro Corp | Company report | 85% |
| Medinotec Inc | Company report | 85% |
| Elutia Inc | Company report | 85% |
| KNW | Company report | 85% |
| BSGM | Company report | 85% |
| Boston Scientific Corporation | Company report | 85% |
| Exact Sciences Corporation | Company report | 85% |
| Inari Medical Inc | Company report | 85% |
| Silk Road Medical Inc | Company report | 85% |
| Inspira Technologies Oxy B H N Ltd | Company report | 85% |
| Retractable Technologies Inc | Company report | 85% |
| Zimmer Biomet Holdings Inc | Company report | 85% |
| Voyager Therapeutics Inc | Company report | 85% |
| Pavmed Inc | Company report | 85% |
| Reshape Lifesciences Inc | Company report | 85% |
| Alphatec Holdings Inc | Company report | 85% |
| Inogen Inc | Company report | 85% |
| Lemaitre Vascular Inc | Company report | 85% |
| Organogenesis Holdings Inc | Company report | 85% |
| Asensus Surgical Inc | Company report | 85% |
| Conmed Corporation | Company report | 85% |
| Orthopediatrics Corp | Company report | 85% |
| The Cooper Companies Inc | Company report | 85% |
| Vicarious Surgical Inc | Company report | 85% |
| Biotricity Inc | Company report | 85% |
| Livanova Plc | Company report | 85% |
| Dexcom Inc | Company report | 85% |
| Tandem Diabetes Care Inc | Company report | 85% |
| Clearpoint Neuro Inc | Company report | 85% |
| Endra Life Sciences Inc | Company report | 85% |
| Smith and Nephew Plc | Company report | 85% |
| Masimo Corp | Company report | 85% |
| Irhythm Holdings Inc | Company report | 85% |
| Surgalign Holdings Inc | Company report | 85% |
| Abiomed Inc | Company report | 85% |
| Zimvie Inc | Company report | 85% |
| Enovis Corp | Company report | 85% |
| Procept Biorobotics Corporation | Company report | 85% |
| Nuvasive Inc | Company report | 85% |
| Inspire Medical Systems inc | Company report | 85% |
| Danaher Corporation | Company report | 85% |
| Johnson and Johnson | Company report | 85% |
| Teleflex Incorporated | Company report | 85% |
| Orthofix Medical Inc | Company report | 85% |
| Merit Medical Systems Inc | Company report | 85% |
| Cardiovascular Systems Inc | Company report | 85% |
| Monogram technologies inc | Company report | 85% |
| Vaso Corporation | Company report | 85% |
| Axonics Inc | Company report | 85% |
| Transmedics Group Inc | Company report | 85% |
| Embecta Corp | Company report | 85% |
| Escalon Medical Corp | Company report | 85% |
| Solana Company | Company report | 85% |
| Lifeward ltd | Company report | 85% |
| Atrion Corporation | Company report | 85% |
| Meihua International Medical Technologies Co Ltd | Company report | 85% |
| Cvrx inc | Company report | 85% |
| Conformis inc | Company report | 85% |
| Fuse Medical Inc | Company report | 85% |
| Icu Medical Inc | Company report | 85% |
| Tactile Systems Technology Inc | Company report | 85% |
| Stereotaxis Inc | Company report | 85% |
| Koru Medical Systems Inc | Company report | 85% |
| Ir med Inc | Company report | 85% |
| Apyx Medical Corp | Company report | 85% |
| Becton Dickinson And Company | Company report | 85% |
| Utah Medical Products Inc | Company report | 85% |
| Myomo Inc | Company report | 85% |
| Icecure Medical Ltd | Company report | 85% |
| Cervomed Inc | Company report | 85% |
| Axogen inc | Company report | 85% |
| Non Invasive Monitoring Systems Inc | Company report | 85% |
| Surmodics Inc | Company report | 85% |
| West Pharmaceutical Services Inc | Company report | 85% |
| Hyperfine Inc | Company report | 85% |
| Assure Holdings Corp | Company report | 85% |
| Milestone Scientific Inc | Company report | 85% |
| Femasys Inc | Company report | 85% |
| Imaging Diagnostic Systems Inc | Company report | 85% |
| Adagio Medical Holdings inc | Company report | 85% |
| Bionik Laboratories Corp | Company report | 85% |
| Electrocore Inc | Company report | 85% |
| Hologic Inc | Company report | 85% |
| Vivani Medical Inc | Company report | 85% |
| Baxter International Inc | Company report | 85% |
| Elite Health Systems Inc | Company report | 85% |
| Universal Biosensors Inc | Company report | 85% |
Competitor Evidence Detail
Company report basis, confidence, active dates and source counts for Intersect Ent Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.